4//SEC Filing
WEINSTEIN MARK L 4
Accession 0001437749-13-002902
CIK 0000822418other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:59 PM ET
Size
14.2 KB
Accession
0001437749-13-002902
Insider Transaction Report
Form 4
BIOCLINICA INCBIOC
WEINSTEIN MARK L
DirectorPresident & CEO
Transactions
- Other
Common Stock
2013-03-13−80,000→ 0 total - Disposition from Tender
Common Stock
2013-03-12$7.25/sh−555,087$4,024,381→ 80,000 total
Footnotes (2)
- [F1]Of such amount, 70,001 shares automatically vested and 110,001 shares were issued to the filing person and were paid for in connection with the change in control that occurred upon the acceptance of shares pursuant to the tender offer (the "Offer") which was launched in connection with the Agreement and Plan of Merger dated January 29, 2013 (the "Merger Agreement") by and among BioCore Holdings, Inc. ("Parent"), BC Acquisition Corp. ("Purchaser") and BioClinica, Inc. On March 12, 2013, all shares which were tendered by the filing person in connection with the Offer were accepted by the Purchaser.
- [F2]Represents 80,000 restricted stock units which were cancelled in connection with the merger transaction effected pursuant to the Merger Agreement in exchange for securities of a privately-held affiliate of Parent.
Documents
Issuer
BIOCLINICA INC
CIK 0000822418
Entity typeother
Related Parties
1- filerCIK 0001167433
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 5:59 PM ET
- Size
- 14.2 KB